Phase I, First in Human (FIH), Randomised, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study in Healthy Volunteers with Mild to Moderate Onychomycosis.

Trial Profile

Phase I, First in Human (FIH), Randomised, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study in Healthy Volunteers with Mild to Moderate Onychomycosis.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 15 Feb 2018

At a glance

  • Drugs HXP-124 (Primary)
  • Indications Onychomycosis
  • Focus Adverse reactions; First in man
  • Sponsors Hexima
  • Most Recent Events

    • 31 Jan 2018 New trial record
    • 24 Jan 2018 According to the Hexima media release, preliminary trial results are expected to be available in mid-late 2018.
    • 24 Jan 2018 According to the Hexima media release, first patient has been dosed in this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top